Kiniksa Pharmaceuticals, Ltd.
NASDAQ:KNSA
22.16 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 183.581 | 107.954 | 122.715 | 122.47 | 114.038 | 46.928 | 307.304 | 45.555 | 55.97 |
| Short Term Investments
| 60.046 | 98.417 | 67.893 | 59.731 | 209.444 | 186.452 | 235.328 | 0 | 0 |
| Cash and Short Term Investments
| 243.627 | 206.371 | 190.608 | 182.201 | 323.482 | 233.38 | 307.304 | 45.555 | 55.97 |
| Net Receivables
| 41.724 | 21.266 | 20.316 | 3.985 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 26.364 | 31.122 | 21.599 | 3.675 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 20.084 | 17.538 | 10.537 | 13.17 | 9.767 | 16.494 | 12.892 | 1.549 | 0.364 |
| Total Current Assets
| 331.799 | 276.297 | 243.06 | 196.446 | 333.249 | 241.627 | 313.75 | 47.104 | 56.334 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 11.038 | 12.665 | 7.043 | 8.384 | 10.617 | 8.325 | 6.356 | 0.125 | 0.084 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 16.25 | 17.25 | 18.25 | 19.25 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 16.25 | 17.25 | 18.25 | 19.25 | 0 | -0.21 | -0.21 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0.21 | 0.21 | 0 | 0 |
| Tax Assets
| 211.151 | 219.283 | 185.495 | 0 | 0.01 | 4.372 | 1.216 | 0.238 | 0.041 |
| Other Non-Current Assets
| 10.315 | 0.827 | 5.824 | 8.72 | 5.588 | 0.21 | 0.643 | 0.025 | 0.008 |
| Total Non-Current Assets
| 248.754 | 250.025 | 216.612 | 36.354 | 16.215 | 12.907 | 8.215 | 0.388 | 0.133 |
| Total Assets
| 580.553 | 526.322 | 459.672 | 232.8 | 349.464 | 254.534 | 321.965 | 47.492 | 56.467 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 2.039 | 8.246 | 7.899 | 1.868 | 0.503 | 5.693 | 10.918 | 1.218 | 0.212 |
| Short Term Debt
| 3.986 | 2.253 | 6.602 | 6.762 | 4.214 | 3.394 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 31.811 | 0.307 | 12 | 38.031 | 29.199 | 20.415 | 0 | 0 | 0 |
| Other Current Liabilities
| 62.785 | 52.86 | 32.565 | 36.194 | 27.129 | 18.743 | 31.636 | 16.212 | 2.09 |
| Total Current Liabilities
| 100.621 | 63.666 | 47.066 | 44.824 | 31.846 | 27.83 | 42.554 | 17.43 | 2.302 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 7.862 | 10.005 | 2.618 | 2.669 | 4.878 | 0.955 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 11.954 | 12 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 1.216 | 0 | 0 |
| Other Non-Current Liabilities
| 33.634 | 1.858 | 1.839 | 0.27 | 0.805 | 0.326 | 0.144 | 119.77 | 79.897 |
| Total Non-Current Liabilities
| 41.496 | 23.817 | 16.457 | 2.939 | 5.683 | 1.281 | 0.144 | 119.77 | 79.897 |
| Total Liabilities
| 142.117 | 87.483 | 63.523 | 47.763 | 37.529 | 29.111 | 42.698 | 137.2 | 82.199 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 119.77 | 79.897 |
| Common Stock
| 0.02 | 0.02 | 0.019 | 0.018 | 0.018 | 0.015 | 0.013 | 0.001 | 0.001 |
| Retained Earnings
| -521.143 | -477.95 | -492.034 | -675.397 | -517.473 | -356.092 | -194.225 | -90.998 | -26.125 |
| Accumulated Other Comprehensive Income/Loss
| -0.163 | 0.006 | 0.044 | -0.066 | -0.034 | 0.033 | -0.004 | -0.052 | -0.024 |
| Other Total Stockholders Equity
| 959.722 | 916.763 | 888.12 | 860.482 | 829.424 | 581.467 | 473.483 | 1.341 | 0.416 |
| Total Shareholders Equity
| 438.436 | 438.839 | -492.034 | -675.397 | -517.473 | -356.092 | -194.225 | -89.708 | -25.732 |
| Total Equity
| 438.436 | 438.839 | -492.034 | -675.397 | -517.473 | -356.092 | -194.225 | -89.708 | -25.732 |
| Total Liabilities & Shareholders Equity
| 580.553 | 526.322 | -428.511 | -627.634 | -479.944 | -326.981 | -151.527 | 47.492 | 56.467 |